Harbor Capital Advisors’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-487
Closed -$153K 749
2023
Q4
$153K Buy
487
+178
+58% +$64.4K 0.03% 390
2023
Q3
$137K Buy
309
+98
+46% +$44.3K 0.03% 392
2023
Q2
$91.4K Sell
211
-37
-15% -$20.8K 0.02% 441
2023
Q1
$147K Buy
+248
New +$139K 0.04% 214

Other funds holding AGL

Harbor Capital Advisors's AGL Position: Q1 2024 in Review

Harbor Capital Advisors sold out of Agilon Health (AGL) in Q1 2024, closing a stake of 487 shares — an estimated $153K sold.

Harbor Capital Advisors first reported a position in AGL in Q1 2023 and held it in 4 quarters. The position peaked at $153K in Q4 2023. 198 funds tracked by Wall St. Rank hold AGL as of Q1 2024.

  • Harbor Capital Advisors reported no remaining Agilon Health position as of Q1 2024 after selling out during the quarter.
  • Harbor Capital Advisors sold 487 Agilon Health shares in Q1 2024, an estimated $153K.
  • Harbor Capital Advisors first reported a position in Agilon Health in Q1 2023 and held it in 4 quarters.
  • Harbor Capital Advisors's Agilon Health position peaked at $153K in Q4 2023.
  • 198 funds tracked by Wall St. Rank held Agilon Health as of Q1 2024.

Based on Harbor Capital Advisors's 13F filing for Q1 2024, filed 13 May 2024.